Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes

References

• Campoli-Richards DM, Monk JP, Price A, Benfield P, Todd PA, Ward A. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1988;35(4):373–447.
   PubMed Web of Science ®Google Scholar
• Kamath R, Singh UV, Udupa N. Evaluation of ciprofloxacin hydrochloride ocular preparations. Ind J Pharm Sci 1993;55(1):148–150.
   Google Scholar
• Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: Past, present, and future perspectives. Int J Antimicrob Agents 2000;16(1):5–15.
   PubMed Web of Science ®Google Scholar
• Tsai AC, Tseng MC, Chang SW, Hu FR. Clinical evaluation of ciprofloxacin ophthalmic solution in the treatment of refractory bacterial keratitis. J Formos Med Assoc 1995;94(12):760–764.
   PubMed Web of Science ®Google Scholar
• Morlet N, Graham G, Gatus B, Mclachlan AJ, Salonikas C, Naidoo D, Goldberg I, Lam CM. Pharmacokinetics of ciprofloxacin in the human eye: A clinical study and population pharmacokinetic analysis. Antimic Agents Chemother 2000;44(6):1674–1679.
   PubMed Web of Science ®Google Scholar
• Ciprofloxacin hydrochloride, analytical report, control no. 197210, WHO Guidelines. WHO/Pharm 1997;595:57–65.
   Google Scholar
• Lee VHL, Robinson JR. Review: Topical ocular drug delivery-recent developments and future challenges. J Ocul Pharmacol 1986;2(1):67–108.
   PubMedGoogle Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular delivery: An overview. Int J Pharm 2004;269(1):1–14.
   PubMedGoogle Scholar
• Topalkara A, Guler C, Arici DS, Arici MK. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol 2000;28(2):113–117.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Van Ooteghem M. Influence of viscolysers on the residence of ophthalmic solutions evaluated by slit lamp fluorophotometry. STP Pharma Sci 1992;2:81–87.
   Web of Science ®Google Scholar
• Edsman K, Carlfors J, Harju K. Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. Int J Pharm 1996;137(2):233–241.
   Google Scholar
• Hui HW, Robinson JR. Ocular drug delivery of progesterone using a bioadhesive polymer. Int J Pharm 1985;26(3):203–213.
   Google Scholar
• Weyenberg W, Vermeire A, Dhondt MM, Adriaens E, Kestelyn P, Remon JP, Ludwig A. Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Invest Ophth Visual Sci 2004;45:3229–3233.
   PubMed Web of Science ®Google Scholar
• Budai L, HajdúM, Budai M, Gróf P, Béni S, Noszál B, Klebovich I, Antal I. Gels and liposomes in optimized ocular drug delivery: Studies on ciprofloxacin formulations. Int J Pharm 2007;343(1–2):34–40.
   PubMedGoogle Scholar
• Nagarsenker MS, Londhe VY, Nadkarni GD. Preparation of liposomal formulation of tropicamide for ocular delivery. Int J Pharm 1999;190(1):63–71.
   PubMedGoogle Scholar
• Lin HH, Ko SM, Hsu LR, Tsai YH. The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig’s eye. J Pharm Pharmacol 1996;48(8) 801–805.
   PubMed Web of Science ®Google Scholar
• Meisner D, Mezei M. Liposome ocular systems. Adv Drug Deliv Rev 1995;16(1):75–93.
   Web of Science ®Google Scholar
• Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: Two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 2002;28(4):353–369.
   PubMed Web of Science ®Google Scholar
• Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 2003;55(11):1451–1463.
   PubMed Web of Science ®Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery: II. Polymer-coated vesicles. Pharm Res 1992;9(9):1137–1144.
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and other natural polymers. Int J Pharm 1992;78(1–3):43–48.
   Google Scholar
• De Campos AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: A new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001;224:(1–2)159–168.
   PubMed Web of Science ®Google Scholar
• Hirano S, Seino H, Akiyama I, Nanaka I. Chitosan: A biocompatible material for oral and intravenous administration. In:Gebelein CG, Dunn RL, editors. Progress in biomedical polymers. New York: Plemun Press; 1990. pp 283–289.
   Google Scholar
• Diebold Y, Jarrín M, Sáez V, Carvalho ELS, Orea M, Calonge M, Seijo B, Alonso MJ. Ocular drug delivery by liposome-chitosan nanoparticles complexes (LCS-NP). Biomat 2007;28(8):1553–1564.
   PubMed Web of Science ®Google Scholar
• Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994;11(9):1358–1361.
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int J Pharm 2003; 260(2):167–173.
   PubMedGoogle Scholar
• Betageri GV, Parsons DL. Drug encapsulation and release from multilamellar and unilamellar liposomes. Int J Pharm 1992;81(2–3):235–241.
   Google Scholar
• Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228 (1–2):43–52.
   PubMedGoogle Scholar
• Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, Mura P. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 2005;298(1):55–67.
   PubMedGoogle Scholar
• El-Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm 1997;158(2):121–127.
   Google Scholar
• Junyaprasert VB, Manwiwattanakul G. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions. Int J Pharm 2008;352(1–2):81–91.
   PubMedGoogle Scholar
• Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm 2002;242(1–2):381–384.
   PubMedGoogle Scholar
• Ceulemans J, Vermeire A, Adriaens E, Remon JP, Ludwig A. Evaluation of a mucoadhesive tablet for ocular use. J Control Release 2001;77(3):333–344.
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 2008;9(3):740–747.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20(6):64–74.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 7th ed. Approved Standard NCCLS Document M2-A7, Vol. 20, No. 1 (ISBN 1-56238-393-0). NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087- 1898, January 2000.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 2003, 6th ed. Wayne, PA7 NCCLS.
   Google Scholar
• Zhu Y, Wilson CG, Meadows D, Olejnik O, Frier M, Washington N, Musson R. Dry powder dosing in liquid vehicles: Ocular tolerance and scintigraphic evaluation of a perfluorocarbon suspension. Inter J Pharm 1999;191:79–85.
   PubMedGoogle Scholar
• Rittenhouse KD, Peiffer RL, Pollack GM. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J Pharm Bio Anal 1998;16:951–959.
   PubMed Web of Science ®Google Scholar
• Colo DG, Burgalassi S, Chetoni P, Fiaschi MP, Zambito Y, Saettone MF. Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. Int J Pharm 2001;215(1–2):101–111.
   PubMedGoogle Scholar
• New RRC. Liposomes: A practical approach. Oxford: Oxford University IRL Press; 1990.
   Google Scholar
• Moribe K, Maruyama K, Iwatsuru M. Encapsulation characteristics of nystatin in liposomes: Effects of cholesterol and polyethylene glycol derivatives. Int J Pharm 1999;188(2):193–202.
   PubMedGoogle Scholar
• Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech 2009;10(1):211–219.
   PubMed Web of Science ®Google Scholar
• Cócera M, López O, Coderch L, Parra JL, De la Maza A. Permeability investigations of phospholipid liposomes by adding cholesterol. Colloids and Surfaces A: Physicochem Eng Aspects 2003;221(1–3):9–17.
   Web of Science ®Google Scholar
• Khalil RM, El-Nahhas SA, Omar SM, El-Ridy MS. Pilocapine hydrochloride liposomal ophthalmic drug delivery system. Egypt J Pharm Sci 1992;33(1):667–678.
   Google Scholar
• Kulkarni SB, Singh M, Betageri GV. Encapsulation, stability and in-vivo release characteristics of liposomal formulations of colchicine. J Pharm Pharmacol 1997;49(5):491–495.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim Biophys Acta 1992;1103(1):94–100.
   PubMedGoogle Scholar
• Law SL, Hung HY. Properties of acyclovir-containing liposomes for potential ocular delivery. Int J Pharm 1998;161(2):253–259.
   Google Scholar
• Finkelestein MC, Weismann G. Enzyme replacement via liposomes: Variation in lipid composition determined liposomal integrity in biological fluid. Biochim Biophys Acta 1979;587(2):202–216.
   PubMedGoogle Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation. Int J Pharm 2006;308(1–2):140–148.
   PubMedGoogle Scholar
• Lo Y, Rahman Y. Protein location in liposomes, a drug carrier: A prediction by differential scanning calorimetry. J Pharm Sci 1995;84(7):805–813.
   PubMed Web of Science ®Google Scholar
• Filipovica-Grcic J, Skalko-Basnet N, Jalsenjak I. Mucoadhesive chitosan-coated liposomes: Characteristics and stability. J Microencap 2001;18(1):3–12.
   PubMed Web of Science ®Google Scholar
• Gruner SM. Materials and properties of liposomal bilayers. In:Ostro MJ, editor. Liposomes from biophysics to therapeutics. New York: Marcel Dekker; 1997:1–38.
   Google Scholar
• Henriksen I, Vagen SR, Sande SA, Smistad G, Karlsen J. Interaction between liposomes and chitosan II: Effect of selected parameters on aggregation and leakage. Int J Pharm 1997;146(2):193–204.
   Google Scholar
• Kellaway IW, Najib NM. Hydrophilic polymers as stabilizers and flocculants of sulphadimidine suspensions. Int J Pharm 1981;9(1):59–66.
   Google Scholar
• Mobed M, Nishiya T, Chang TMS. Preparation of carboxymethylichitin-incorporated submicron bilayer lipid membrane artificial cells (liposomes) encapsulating hemoglobin. Biomater Artif Cells Immobil Biotech 1992;20(2–4):365–368.
   PubMedGoogle Scholar
• Rengel RG, Barisic K, Pavelic Z, Grubisic TZ, Cepelak I, Filipovic-Grcic J. High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur J Pharm Sci 2002;15(5):441–448.
   PubMed Web of Science ®Google Scholar
• Zaru M, Manca ML, Fadda AM, Antimisiaris SG. Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloids Surfaces B: Biointerfaces 2009;71(1):88–95.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003;86(2–3):235–242.
   PubMed Web of Science ®Google Scholar